ALK and neoplasm: In a non-selected stage I-III NSCLC population, Paik et al. [32] reported lower tumor stage (pT1) and significantly higher frequency of lymph node metastases in ALK FISH-positive NSCLC cases compared to ALK FISH-negative NSCLC cases.